🇺🇸 FDA
Patent

US 8007804

Complement receptor 2 targeted complement modulators

granted A61KA61K38/00A61P

Quick answer

US patent 8007804 (Complement receptor 2 targeted complement modulators) held by The Regents of the University of Colorado expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/04